@tradrjoze @JamesPe11062557 @sparky6871 https://t.co/SIpKCTSOBe Even JAMA agrees. DCVAX is ALT-DC Commercially manufactured by $NWBO Soon to the world. Now f*ck off. 🖕🏽😎 https://t.co/e6L4ONTPq1
RT @flaskworks: @Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr…
RT @flaskworks: @Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr…
RT @flaskworks: @Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr…
RT @flaskworks: @Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr…
@Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr Linda Liau using $NWBO DCVax, Keytruda, PolyICLC. https://t.co/UbQi4GbIF9 https://t.co/NDF2KDCG6C With nontoxic therapies tumor s
$nwbo civil spoofing case w underlying naked shorting 3000 FTD’s Also they FLIPPED the SDNY #aviperry lawyer (who’d prosecuted Harrington) & is now working the defense?! Proven #jama cure for GBM cancer plus #allhardtumors #gbm https://t.co/4tfnBnRRy
RT @alphavestcap: $nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonran…
RT @alphavestcap: $nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonran…
@VivekSubbiah @NEJM Why would CAR-T be preferable option to DCVax which targets all antigens and neoantigens on the heterogeneous Glioblastoma tumor while doesn't induce cytokine storms? https://t.co/UbQi4GcguH
RT @alphavestcap: $nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonran…
$nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statisti
$nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statisti
$nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statisti
$nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statisti
https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statistically significant exte
$nwbo @alphavestcap @EAntonioChiocca (https://t.co/zla7ZiMHuv) says dc vax l trial is a failure based on PFS . (https://t.co/bhUDKROm2Z) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associa
RT @rsloftx: @ChuckCallesto $DCVax by $nwbo to be approved by MHRA in the UK shortly and the phase 3 results reported in JAMA Oncology in N…
RT @rsloftx: @ChuckCallesto $DCVax by $nwbo to be approved by MHRA in the UK shortly and the phase 3 results reported in JAMA Oncology in N…
RT @rsloftx: @ChuckCallesto $DCVax by $nwbo to be approved by MHRA in the UK shortly and the phase 3 results reported in JAMA Oncology in N…
RT @rsloftx: @ChuckCallesto $DCVax by $nwbo to be approved by MHRA in the UK shortly and the phase 3 results reported in JAMA Oncology in N…
@ChuckCallesto $DCVax by $nwbo to be approved by MHRA in the UK shortly and the phase 3 results reported in JAMA Oncology in Nov '22. You can also learn about their MM HF spoofing lawsuit against @Citadel and others via Cohen Milstein lawfirm. https://t.
https://t.co/xSutNbHxTS $nwbo @alphavestcap
@hayleyinvests December 2023 @NorthwestBio submits MAA application for treating Glioblastoma. https://t.co/PHwFvBh4vb Despite amazing results $NWBO remains heavily manipulated stock. https://t.co/UbQi4GbIF9 https://t.co/dLGtjeV7bR Longs see the Amazon
RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…
RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…
RT @alphavestcap: @andrewcaravello $nwbo @alphavestcap #DCVax is the only personalized cancer vaccine platform that has a successful phas…
RT @alphavestcap: @andrewcaravello $nwbo @alphavestcap #DCVax is the only personalized cancer vaccine platform that has a successful phas…
@andrewcaravello $nwbo @alphavestcap #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWBO #AllSolidTumors #NoSideAffects #ItsANoBrainer #CancerMoonShot https://t.co/bhUDKROm2Z
RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…
RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…
RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…
RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…
RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…
RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…
https://t.co/gAcGlUXZVL $nwbo @alphavestcap
RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…
RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…
#DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWBO #AllSolidTumors #NoSideAffects #ItsANoBrainer #CancerMoonShot https://t.co/hRKyehHT1i
@MikePhi46301694 @mattkolleck1 @Nina_kd @d_stock07734 https://t.co/V86zey58Hi Prespecified endpoints met with stat significance- the definition of a successful trial. Published here: 🙂
https://t.co/NFLd7NPhPh @alphavestcap $nwbo https://t.co/Sn9liYLIap https://t.co/bhUDKROm2Z https://t.co/MTNivDXzFu https://t.co/aHhf0zrUGn https://t.co/rlJJOgy1Ej https://t.co/gXASnJvugw https://t.co/gXASnJvugw Bear:By 7/1/24 NWBO’s dc vax L should have
RT @sharpie510: $NWBO published #DCVax-L results on Nov 17, 2022. Statistically significant extension of mOS for BOTH new and recurrent #gb…
RT @sharpie510: $NWBO published #DCVax-L results on Nov 17, 2022. Statistically significant extension of mOS for BOTH new and recurrent #gb…
RT @sharpie510: $NWBO published #DCVax-L results on Nov 17, 2022. Statistically significant extension of mOS for BOTH new and recurrent #gb…
$NWBO published #DCVax-L results on Nov 17, 2022. Statistically significant extension of mOS for BOTH new and recurrent #gbm! 💪 Patients have been hoping for approval. 547 patients die EVERY DAY from #glioblastoma worldwide. 🙏 https://t.co/NtsI06bbmg htt
RT @KauriCapital: @GavinPrestonMD #DcVax by $NWBO @NorthwestBio is missing from 2023 breakthroughs https://t.co/Ji7W5ADn9h…
@GavinPrestonMD #DcVax by $NWBO @NorthwestBio is missing from 2023 breakthroughs https://t.co/Ji7W5ADn9h https://t.co/kBn2SY7mGP
Now look at the DCVax-L P3 trial https://t.co/ERNiu12gIg Go to grants and funding at the bottom and here is the same grant. Click it. https://t.co/kAXaziXI9m
RT @flaskworks: @hoffmann6383 @Edpilkington Journalistic malpractice: "Perhaps the most shocking finding of all was that brain cancer clin…
@hoffmann6383 @Edpilkington Journalistic malpractice: "Perhaps the most shocking finding of all was that brain cancer clinical trial completion rates have significantly decreased — from 78% to 64%. In short: we are going backwards." Forgot $NWBO's stat
RT @rago_carlo: These cancer vaccine results are breathtaking! rGBM 2yr survival ~10%, Physician's Choice, i.e. "SOC" ~20%, DCVax-L + "SOC…
RT @rago_carlo: These cancer vaccine results are breathtaking! rGBM 2yr survival ~10%, Physician's Choice, i.e. "SOC" ~20%, DCVax-L + "SOC…
RT @rago_carlo: These cancer vaccine results are breathtaking! rGBM 2yr survival ~10%, Physician's Choice, i.e. "SOC" ~20%, DCVax-L + "SOC…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @sharpie510: @FlemmingBruce This reporter [email protected]">@industrydive.com">[email protected] clearly hasn't heard about the groundbreaking $NWBO #DCVax-L phase 3…
RT @sharpie510: @FlemmingBruce This reporter [email protected]">@industrydive.com">[email protected] clearly hasn't heard about the groundbreaking $NWBO #DCVax-L phase 3…
@FlemmingBruce This reporter [email protected]">@industrydive.com">[email protected] clearly hasn't heard about the groundbreaking $NWBO #DCVax-L phase 3 results ALREADY PEER-REVIEWED & PUBLISHED IN JAMA. Or maybe he has. Statistically significant OS extension in BOTH new & re
@01Core_Ben @venuv62 @Noahpinion Huang says that because he wants to sustain an unsustainable share price. To my knowledge $NWBO didn't use a single $NVDA GPU for their revolutionary cancer vaccine, DCVax. AI will never replace the wet lab. https://t.c
RT @flaskworks: @dollarsanddata Time to look into $NWBO? https://t.co/UbQi4GbIF9
@dollarsanddata Time to look into $NWBO? https://t.co/UbQi4GbIF9
RT @flaskworks: @SnackBioTech @bohsie If you don't know the $NWBO trial data then maybe you shouldn't keep trolling the future SOC for brai…
https://t.co/bhUDKROm2Z… https://t.co/AqCgR5j5dY… https://t.co/v7s3GQwO01 $nwbo @alphavestcap
@SnackBioTech @bohsie If you don't know the $NWBO trial data then maybe you shouldn't keep trolling the future SOC for brain cancer patients. https://t.co/UbQi4GbIF9 https://t.co/NDF2KDCG6C https://t.co/T1G8rSgaQy
https://t.co/2rkIgxH1Uq In the P3 trail, documented by the JAMA scientific publication (11/17/22), what % of the dosed patients( c. 300 ?) lived longer ? $nwbo @alphavestcap https://t.co/bhUDKROm2Z
RT @GoneGoodguy: You've been saying that for decades. #NWBO will not go bankrupt. SHFs couldn't stop NWBO when they had the stock on the ro…
@tradrjoze He has a right to his opinions, but the JAMA article, along with the plethora of doctors who support this, outweighs his statement: https://t.co/kMftDjsZ31
RT @GoneGoodguy: You've been saying that for decades. #NWBO will not go bankrupt. SHFs couldn't stop NWBO when they had the stock on the ro…
You've been saying that for decades. #NWBO will not go bankrupt. SHFs couldn't stop NWBO when they had the stock on the ropes at 14 cents. Surely, they can't stop it now! Here's a few reasons why: 1.https://t.co/kLHpSzE65Z 2. https://t.co/wTpMKKf44S 3.
@davidasinclair Well worth looking into IMO. Three places to start: The P3 trial: https://t.co/CyiZz8aWF2 Proteomics analysis presentation: https://t.co/rLzNWzc6gz Upcoming combo trial results in Nature (preprint atm): https://t.co/bdlxG2N5QS Future
@Pharmdca Then check out some recent research out of UCLA using $NWBO's DCVax. https://t.co/UbQi4GbIF9 https://t.co/NDF2KDCG6C
@jarlebreivik fokuserer på Glioblastoma multiforme, fase 3 studiet er nå er sendt inn til MHRA, for evaluering til en potensiell godkjenning. Resultatene er publisert i prestisjetunge JAMA oncologi https://t.co/ZXY9rbhsAx
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @miltommy56: Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/l4bp50sLaP
RT @miltommy56: Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/l4bp50sLaP
Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/l4bp50sLaP
@locuta Bij mijn weten is er geen Ned team betrokken bij deze klinische trial, maar ze zou het kunnen navragen bij het oncologische team van AvL. DCVax-L is een vaccin dat de prognose significant lijkt te verbeteren. Er zijn patienten gemeld met 8jr overl
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
RT @Dave46217976: $NWBO #DCVAX
RT @Dave46217976: $NWBO #DCVAX
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
$NWBO #DCVAX